H.G. Meerpohl

1.8k total citations
27 papers, 1.1k citations indexed

About

H.G. Meerpohl is a scholar working on Oncology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, H.G. Meerpohl has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 6 papers in Surgery and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in H.G. Meerpohl's work include Cancer Treatment and Pharmacology (11 papers), Ovarian cancer diagnosis and treatment (5 papers) and HER2/EGFR in Cancer Research (5 papers). H.G. Meerpohl is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), Ovarian cancer diagnosis and treatment (5 papers) and HER2/EGFR in Cancer Research (5 papers). H.G. Meerpohl collaborates with scholars based in Germany, Switzerland and Estonia. H.G. Meerpohl's co-authors include Marie‐Luise Lohmann‐Matthes, Herbert Fischer, Andreas du Bois, Jalid Sehouli, H Engler, G. W. Löhr, Wolfram Brugger, Reinhard Andreesen, Stefan W. Krause and Carmen Scheibenbogen and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Immunology and European Journal of Cancer.

In The Last Decade

H.G. Meerpohl

26 papers receiving 1.0k citations

Peers

H.G. Meerpohl

ONCOL

SURGE

IMMUN

Darren Ennis United Kingdom

Elisa Schmoeckel Germany

Masatoshi Yokoyama Japan

Gudrun Pohl Austria

Catherine Ross Canada

Karen Oliva Australia

Simona Scalone Italy

Katie Meehan Australia

J Koudstaal Netherlands

Vladimír Bobek Czechia

Darren Ennis United Kingdom

H.G. Meerpohl

566 ×1.4

ONCOL

332 ×0.9

231 ×0.8

SURGE

260 ×1.2

IMMUN

90 ×0.6

Citations per year, relative to H.G. Meerpohl H.G. Meerpohl (= 1×) peers Darren Ennis

Countries citing papers authored by H.G. Meerpohl

Since Specialization

Citations

This map shows the geographic impact of H.G. Meerpohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.G. Meerpohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.G. Meerpohl more than expected).

Fields of papers citing papers by H.G. Meerpohl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.G. Meerpohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.G. Meerpohl. The network helps show where H.G. Meerpohl may publish in the future.

Co-authorship network of co-authors of H.G. Meerpohl

This figure shows the co-authorship network connecting the top 25 collaborators of H.G. Meerpohl. A scholar is included among the top collaborators of H.G. Meerpohl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.G. Meerpohl. H.G. Meerpohl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Untch, Michael, M Muscholl, Sergei Tjulandin, et al.. (2010). First-Line Trastuzumab Plus Epirubicin and Cyclophosphamide Therapy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Cardiac Safety and Efficacy Data From the Herceptin, Cyclophosphamide, and Epirubicin (HERCULES) Trial. Journal of Clinical Oncology. 28(9). 1473–1480. 55 indexed citations

Stemmler, Hans‐Joachim, Nadia Harbeck, Wolfgang Abenhardt, et al.. (2010). Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel (D2) for First-Line Treatment of Metastatic Breast Cancer. Oncology. 79(3-4). 197–203. 20 indexed citations

Stemmler, Hans‐Joachim, Nadia Harbeck, Wolfgang Abenhardt, et al.. (2010). Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel plus Doxorubicin (D4) for First-Line Treatment of Metastatic Breast Cancer. Oncology. 79(3-4). 204–210. 7 indexed citations

Backhaus, Juergen, et al.. (2010). Diagnosis of breast cancer with infrared spectroscopy from serum samples. Vibrational Spectroscopy. 52(2). 173–177. 98 indexed citations

Sehouli, Jalid, Dirk Stengel, Philipp Harter, et al.. (2010). Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: A Randomized Multicenter Phase II Trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group. Journal of Clinical Oncology. 29(2). 242–248. 76 indexed citations

Stemmler, Hans‐Joachim, Peter A. Fasching, F. Melchert, et al.. (2007). Gemcitabine and Carboplatin in Intensively Pretreated Patients with Metastatic Breast Cancer. Oncology. 73(5-6). 407–414. 20 indexed citations

Al‐Batran, Salah‐Eddin, H.G. Meerpohl, Gϋnter von Minckwitz, et al.. (2006). Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m<sup>2</sup> Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer. Oncology. 70(2). 141–146. 44 indexed citations

Harter, Philipp, Andreas du Bois, Maik Hahmann, et al.. (2006). Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial. Annals of Surgical Oncology. 13(12). 1702–1710. 275 indexed citations

Untch, Michael, Steffen Kahlert, Holger Eidtmann, et al.. (2004). Anthracycline and trastuzumab in breast cancer treatment.. PubMed. 18(14 Suppl 14). 59–64. 6 indexed citations

10.

Untch, Michael, Holger Eidtmann, Andreas du Bois, et al.. (2004). Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer. European Journal of Cancer. 40(7). 988–997. 39 indexed citations

11.

Langer, Bernd, M Muscholl, M. Pauschinger, et al.. (2004). Prospective investigation of the significance of cardiac markers, NT-pro Brain Natriuretic Peptide (NT-proBNP) and Troponin T (TnT), in the Hercules study of epirubicin/cyclophosphamide with or without trastuzumab (Herceptin®). European Journal of Cancer Supplements. 2(3). 143–143. 2 indexed citations

12.

Bois, Andreas du, et al.. (1999). Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy. Supportive Care in Cancer. 7(5). 354–361. 31 indexed citations

13.

Lück, Hans‐Joachim, Christoph Thomssen, Andreas duBois, et al.. (1996). Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer.. PubMed. 23(1 Suppl 1). 33–6. 21 indexed citations

14.

Bois, Andreas du, et al.. (1996). Pathophysiology, Severity, Pattern, and Risk Factors for Carboplatin-induced Emesis. Oncology. 53(1). 46–50. 16 indexed citations

15.

Andreesen, Reinhard, Carmen Scheibenbogen, Wolfram Brugger, et al.. (1990). Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy.. PubMed. 50(23). 7450–6. 170 indexed citations

16.

Meerpohl, H.G., et al.. (1990). Das Rezidiv in der gynäkologischen Onkologie. 1 indexed citations

17.

Meerpohl, H.G., et al.. (1990). Phase II study of carboplatin/ifosfamide in untreated advanced cervical cancer. Cancer Chemotherapy and Pharmacology. 26(S1). S33–S35. 21 indexed citations

18.

Meerpohl, H.G. & Thomas Bauknecht. (1986). Role of prostaglandins on the regulation of macrophage proliferation and cytotoxic functions. Prostaglandins. 31(5). 961–972. 13 indexed citations

19.

Lohmann‐Matthes, Marie‐Luise, Wolfgang Domzig, & H.G. Meerpohl. (1977). Mouse bone marrow‐cultured macrophage as indicator cells for mouse and human migration inhibitory factor (MIF). European Journal of Immunology. 7(8). 585–588. 7 indexed citations

20.

Meerpohl, H.G., Marie‐Luise Lohmann‐Matthes, & Herbert Fischer. (1976). Studies on the activation of mouse bone marrow‐derived macrophages by the macrophage cytotoxicity factor (MCF). European Journal of Immunology. 6(3). 213–217. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact